Quintrio
Home

SERVICES-HOME HEALTH CARE SERVICES

Chemed Corporation

CHE

Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.

Last trade $547.67
Day change -$1.785 (-0.32%)
Day range $544.31 – $551.47
Volume 66,134
Market cap $7.12B

Open XNYS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$7.12B
Price / earnings
25.22×
Price / book
8.27×
Price / sales
2.68×
EV / sales
2.75×
EV / EBITDA
16.67×

Profitability

Earnings per share
$21.79
Return on assets
16.43%
Return on equity
32.78%
Dividend yield
0.47%

Liquidity and leverage

Debt / equity
0.27×
Current ratio
1.11×
Quick ratio
1.08×
Cash ratio
0.15×

Cash flow

Price / cash flow
19.61×
Price / free cash flow
24.1×
Free cash flow
$295.45M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for CHE, quarterly periods
Line itemQ3 FY2026 Sep 30, 2026Q2 FY2026 Jun 30, 2026Q1 FY2026 Mar 31, 2026Q4 FY2025 Dec 31, 2025Q3 FY2025 Sep 30, 2025Q2 FY2025 Jun 30, 2025Q1 FY2025 Mar 31, 2025Q4 FY2024 Dec 31, 2024
Revenue$690.94M$673.25M$657.51M$639.34M$624.9M$618.8M$646.94M$639.99M
Cost of revenue$457.98M$451.78M$441.75M$414.17M$425.14M$434.11M$430.53M$405.88M
Gross profit$232.96M$221.47M$215.76M$225.17M$199.76M$184.69M$216.41M$234.12M
Selling, general and administrative$111.47M$115.2M$114.32M$105.5M$105.78M$100.32M$105.59M$104.25M
Research and development$0$0$0$0$0$0$0$0
Total operating expenses$136.54M$132.27M$131.19M$124.52M$125.01M$116.61M$121.66M$120.24M
Operating income$96.42M$89.2M$84.58M$100.65M$74.75M$68.08M$94.76M$113.88M
Interest expense-$2.1M-$1.79M-$512K-$521K-$457K-$443K-$329K-$499K
Income before taxes$96.71M$91.33M$88.84M$105.45M$83.54M$71.12M$95.67M$120.12M
Income taxes$25.06M$23.63M$22.54M$28.69M$19.31M$18.62M$23.92M$29.8M
Net income$71.65M$67.7M$66.3M$76.75M$64.24M$52.49M$71.76M$90.32M
Net income attributable to common shareholders$71.65M$67.7M$66.3M$76.75M$64.24M$52.49M$71.76M$90.32M
EBITDA$113.82M$106.19M$101.45M$116.98M$90.98M$84.34M$110.78M$129.71M
Basic earnings per share$5.49$5.14$4.85$5.49$4.46$3.60$4.91$6.08
Diluted earnings per share$5.45$5.13$4.84$5.50$4.46$3.57$4.86$6.03

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
Zacks Investment Research

Here's Why Chemed (CHE) is a Strong Momentum Stock

Chemed Corporation (CHE), a Cincinnati-based diversified business operator, is highlighted as a stock to watch with a #3 (Hold) Zacks Rank and an A VGM Score. The company demonstrates strong momentum with shares up 7.5% over the past four weeks, and analysts have revised fiscal 2026 earnings estimates upward by $0.18 to $25.77 per share, with an average earnings surprise of +3.9%.

Zacks Investment Research

Chemed (CHE) Tops Q3 Earnings and Revenue Estimates

Chemed reported Q3 2026 earnings of $6.75 per share, beating consensus estimates of $6.39, with revenues of $690.94 million exceeding expectations. Despite the beat and 19.9% year-to-date outperformance versus the S&P 500, the company received a Zacks Rank #4 (Sell) rating due to unfavorable estimate revision trends ahead of the earnings release. The Medical - Outpatient and Home Healthcare industry ranks in the bottom 36% of Zacks industries.

Investing.com

These 8 Stocks Yield Up to 8.3% and Their Payouts Could Soon Rise

The article highlights eight dividend-paying stocks with yields up to 8.3% that are expected to increase their payouts soon. These companies have demonstrated strong earnings growth and maintain low payout ratios, suggesting room for dividend increases. The stocks span various sectors including construction, healthcare, aerospace, HVAC, telecommunications, tobacco, investment management, and energy infrastructure.

GlobeNewswire Inc.

Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend

Chemed Corporation held its 2026 annual stockholders meeting where nine directors were elected and PricewaterhouseCoopers LLP was ratified as independent accountants. However, the non-binding proposal on executive compensation was not approved. The board declared a quarterly cash dividend of $0.60 per share, marking the 220th consecutive quarterly dividend in the company's 55-year history as a public company.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

Ex-dividendAmount / sharePay dateType
Nov 16, 2026$0.70Dec 4, 2026recurring
Aug 17, 2026$0.70Sep 3, 2026recurring
May 28, 2026$0.60Jun 16, 2026recurring
Feb 23, 2026$0.60Mar 13, 2026recurring
Nov 17, 2025$0.60Dec 5, 2025recurring

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
May 12, 20052-for-1forward split